Bocidelpar
Bocidelpar (ASP0367; MA-0211) is a selective, orally active PPARδ modulator. Bocidelpar activates the PPARδ downstream signaling pathway, upregulates the expression of target genes such as ABCA1 and ACAA2. Bocidelpar then promotes fatty acid oxidation (FAO) and mitochondrial biogenesis, and improves mitochondrial dysfunction. Bocidelpar can improve mitochondrial biogenesis and function in muscle cells. Bocidelpar is mainly used in the study of mitochondrial dysfunction diseases such as primary mitochondrial myopathy (PMM) and Duchenne muscular dystrophy (DMD) [1][2].
Product Specifications
CAS Number
2095128-20-2
Product Name Alternative
ASP0367; MA-0211
UNSPSC
12352005
Target
PPAR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/bocidelpar.html
Purity
98.08
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(O)C[C@H](C)CCCOC1=CC=CC=C1CN2C(C)=CN=C2C3=CC=C(C(F)(F)F)C=C3
Molecular Formula
C25H27F3N2O3
Molecular Weight
460.49
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TPPP, ID (TPPP, TPPP1, Tubulin polymerization-promoting protein, 25kD brain-specific protein, TPPP/p25, p24, p25-alpha) (MaxLight 650)
TPPP, ID (TPPP, TPPP1, Tubulin polymerization-promoting protein, 25kD brain-specific protein, TPPP/p25, p24, p25-alpha) (MaxLight 650)
Rabbit Polyclonal AARS2 Antibody [DyLight 594]